Estimation of new HIV diagnosis rates among high‐risk, PrEP‐eligible individuals using HIV surveillance data at the Metropolitan Statistical Area level in the United States-Reference-Cited by-同舟云学术

Estimation of new HIV diagnosis rates among high‐risk, PrEP‐eligible individuals using HIV surveillance data at the Metropolitan Statistical Area level in the United States

Published:2019-12 Issue:12 Volume:22 Page:
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:J Intern AIDS Soc

Author:

Mera Robertino¹,Scheer Susan²,Carter Christoph¹^ORCID,Das Moupali¹,Asubonteng Julius¹^ORCID,McCallister Scott¹^ORCID,Baeten Jared³^ORCID

Affiliation:

1. Gilead Sciences, Inc Foster City CA USA

2. San Francisco Department of Public Health San Francisco CA USA

3. Departments of Global Health, Medicine and Epidemiology University of Washington Seattle WA USA

Funder

Gilead Sciences

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jia2.25433

Reference26 articles.

1. HessK JohnsonS HuX LiJ WuB YuC et al.Diagnoses of HIV Infection in the United States and Dependent Areas 2017[Internet].2017[cited 2019 Jan 29]. Available from:http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html

2. Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women

3. Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

4. Preexposure prophylaxis for the prevention of HIV infection in the United States – 2017 Update[Internet].2017[cited 2019 Jan 29]. Available from:https://www.cdc.gov/std/tg2015/tg-2015

5. Guidance on pre‐exposure oral prophylaxis (PrEP) for serodiscordant couples men and transgender women who have sex with men at high risk of HIV[Internet].2012[cited 2019 Jan 29]. Available from:http://www.who.int/about/licensing/

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States;PharmacoEconomics;2024-01-24

2. Estimating HIV Incident Diagnoses Among Men Who Have Sex With Men Eligible for Pre-exposure Prophylaxis but Not Taking It: Protocol and Feasibility Assessment of Data Sources and Methods;JMIR Research Protocols;2023-03-07

3. An overview of programmatic indicators to monitor the roll-out of HIV preexposure prophylaxis;AIDS;2023-01-01

4. Estimating HIV Incident Diagnoses Among Men Who Have Sex With Men Eligible for Pre-exposure Prophylaxis but Not Taking It: Protocol and Feasibility Assessment of Data Sources and Methods (Preprint);2022-08-29

5. Improving access to pre-exposure prophylaxis for HIV prescribing in a primary care setting;BMJ Open Quality;2022-05